Comparative proteomic analysis of advanced serous epithelial ovarian carcinoma: Possible predictors of chemoresistant disease

OMICS A Journal of Integrative Biology

Volumn 15, Issue 5, 2011, Pages 281-292

  Kim, Sang Wun ^a   Kim, Sunghoon ^a   Nam, Eun Ji ^a   Jeong, Yong Wook ^a   Lee, San Hui ^a   Paek, Ji Heum ^a   Kim, Jae Hoon ^a   Kim, Jae Wook ^b   Kim, Young Tae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Catholic Kwandong University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BIOLOGICAL MARKER; CARBOPLATIN; CREATINE KINASE BB; CYTOKERATIN 1; DOCETAXEL; GUANINE NUCLEOTIDE EXCHANGE FACTOR; LIPOCORTIN 5; PACLITAXEL; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE E1BETA SUBUNIT PRECURSOR PROTEIN; SH3 CONTAINING GUANINE NUCLEOTIDE EXCHANGE FACTOR; SIMILAR TO RIKEN CDNA 1700016G05 PROTEIN; THIOREDOXIN DOMAIN CONTAINING 4 PROTEIN; TRYPTOPHAN ASPARTATE REPEAT PROTEIN 1; TRYPTOPHAN ASPARTATE REPEAT PROTEIN 1 ISOFORM 1; TUBULIN ALPHA1A CHAIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; ARTICLE; COMPARATIVE STUDY; HUMAN; HUMAN TISSUE; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SENSITIVITY AND SPECIFICITY;

ADULT; CYSTADENOCARCINOMA, SEROUS; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; PROTEOMICS; ROC CURVE; SURVIVAL ANALYSIS;

NUCLEOPOLYHEDROVIRUS;

EID: 79956062762     PISSN: 15362310     EISSN: 15362310     Source Type: Journal    
DOI: 10.1089/omi.2010.0012     Document Type: Article

References (40)

1. Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., et al. (1996). FAN, a novel WDrepeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86, 937-947. (Pubitemid 26336798)
2. Adler, H.J., Winnicki, R.S., Gong, T.W., and Lomax, M.I. (1999). A gene upregulated in the acoustically damaged chick basilar papilla encodes a novel WD40 repeat protein. Genomics 56, 59-69. (Pubitemid 29107204)
3. Armstrong, D.K., Bundy, B., Wenzel, L., Huang, H.Q., Baergen, R., Lele, S., et al. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354, 34-43. (Pubitemid 43048949)
4. Bachvarov, D., L'Esperance, S., Popa, I., Bachvarova, M., Plante, M., and Tetu, B. (2006). Gene expression patterns of chemoresistant and chemosensitive serous epithelial ovarian tumors with possible predictive value in response to initial chemotherapy. Int J Oncol 29, 919-933.
5. Baek, S.J., Park, J.Y., Kim, D.Y., Kim, J.H., Kim, Y.M., Kim, Y.T., et al. (2008). Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. JGynecol Oncol 19, 223-228.
6. Barreiro, O., Yanez-Mo, M., Serrador, J.M., Montoya, M.C., Vicente-Manzanares, M., Tejedor, R., et al. (2002). Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157, 1233-1245. (Pubitemid 34847793)
7. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
8. Cicchillitti, L., Di Michele, M., Urbani, A., Ferlini, C., Donati, M.B., Scambia, G., et al. (2009). Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. J Proteome Res 8, 1902-1912.
9. Cole, S.P., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., et al. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654. (Pubitemid 23012438)
10. Di Michele, M., Della Corte, A., Cicchillitti, L., Del Boccio, P., Urbani, A., Ferlini, C., et al. (2009). A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 1794, 225-236.
11. DiSaia, P.J., and Creasman, W.T. (2007). Clinical Gynecologic Oncology, 7th ed. (Mosby, St. Louis, MO)
12. du Bois, A., Luck, H.J., Meier, W., Adams, H.P., Mobus, V., Costa, S., et al. (2003). A randomized clinical trial of cisplatin/ paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95, 1320-1329.
13. Gadducci, A., Cosio, S., Carpi, A., Nicolini, A., and Genazzani, A.R. (2004). Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother 58, 24-38. (Pubitemid 38117046)
14. Gogoi, R., Srinivasan, S., and Fishman, D.A. (2006). Progress in biomarker discovery for diagnostic testing in epithelial ovarian cancer. Expert Rev Mol Diagn 6, 627-637. (Pubitemid 44179947)
15. Gottesman, M.M., Fojo, T., and Bates, S.E. (2002). Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2, 48-58. (Pubitemid 37328807)
16. Hartmann, L.C., Lu, K.H., Linette, G.P., Cliby, W.A., Kalli, K.R., Gershenson, D., et al. (2005). Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy. Clin Cancer Res 11, 2149-2155. (Pubitemid 40490171)
17. Huddleston, H.G., Wong, K.K., Welch, W.R., Berkowitz, R.S., and Mok, S.C. (2005). Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker. Gynecol Oncol 96, 77-83. (Pubitemid 39612421)
18. Kim, S.W., Kim, J.W., Kim, Y.T., Kim, J.H., Kim, S., Yoon, B.S., et al. (2007). Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer 46, 1-9. (Pubitemid 44772867)
19. Koukourakis, M.I., Giatromanolaki, A., Sivridis, E., Gatter, K.C., and Harris, A.L. (2005). Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7, 1-6. (Pubitemid 40209465)
20. Le Moguen, K., Lincet, H., Deslandes, E., Hubert-Roux, M., Lange, C., Poulain, L., et al. (2006). Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10. Proteomics 6, 5183-5192. (Pubitemid 44549991)
21. Lessin, S.R., Huebner, K., Isobe, M., Croce, C.M., and Steinert, P.M. (1988). Chromosomal mapping of human keratin genes: evidence of non-linkage. J Invest Dermatol 91, 572-578. (Pubitemid 19016558)
22. Liliental, J., and Chang, D.D. (1998). Rack1, a receptor for activated protein kinase C, interacts with integrin beta subunit. J Biol Chem 273, 2379-2383. (Pubitemid 28069294)
23. McGuire, W.P., Hoskins, W.J., Brady, M.F., Kucera, P.R., Partridge, E.E., Look, K.Y., et al. (1996). Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 334, 1-6. (Pubitemid 26012496)
24. Micha, J.P., Goldstein, B.H., Mattison, J.A., Bader, K., Graham, C., Rettenmaier, M.A., et al. (2005). Experience with singleagent paclitaxel consolidation following primary chemotherapy with carboplatin, paclitaxel, and gemcitabine in advanced ovarian cancer. Gynecol Oncol 96, 132-135. (Pubitemid 39612427)
25. Mitsuzawa, H., Seino, H., Yamao, F., and Ishihama, A. (2001). Two WD repeat-containing TATA-binding protein-associated factors in fission yeast that suppress defects in the anaphasepromoting complex. J Biol Chem 276, 17117-17124.
26. Monastyrskaya, K., Babiychuk, E.B., Hostettler, A., Rescher, U., and Draeger, A. (2007). Annexins as intracellular calcium sensors. Cell Calcium 41, 207-219. (Pubitemid 46201502)
27. Oakley, B.R., Kirsch, D.R., and Morris, N.R. (1980). A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105, 361-363.
28. Ozols, R.F., Bundy, B.N., Greer, B.E., Fowler, J.M., Clarke- Pearson, D., Burger, R.A., et al. (2003). Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21, 3194-3200. (Pubitemid 46606249)
29. Partheen, K., Levan, K., Osterberg, L., and Horvath, G. (2006). Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors. Eur J Cancer 42, 2846-2854. (Pubitemid 44584671)
30. Peters, D., Freund, J., and Ochs, R.L. (2005). Genome-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells. Mol Cancer Ther 4, 1605-1616. (Pubitemid 41556444)
31. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M., (1996). Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68, 850-858.
32. Skinner, E.N., Boruta, D.M., Gehrig, P.A., Boggess, J.F., Fowler, W.C., JR., and Van Le, L. (2005). Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up. Gynecol Oncol 98, 59-62. (Pubitemid 40826419)
33. Song, J., Shih IeM., Salani, R., Chan, D.W., and Zhang, Z. (2007). Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin Cancer Res 13, 6842-6849. (Pubitemid 350206823)
34. Stewart, J.J., White, J.T., Yan, X., Collins, S., Drescher, C.W., Urban, N.D., et al. (2006). Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5, 433-443.
35. Tetu, B., Popa, I., Bairati, I., L'Esperance, S., Bachvarova, M., Plante, M., et al. (2008). Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas. Mod Pathol 21, 1002-1010.
36. Van Buul, J.D., Allingham, M.J., Samson, T., Meller, J., Boulter, E., Garcia-Mata, R., et al. (2007). RhoG regulates endothelial apical cup assembly downstream from ICAM1 engagement and is involved in leukocyte trans-endothelial migration. J Cell Biol 178, 1279-1293. (Pubitemid 47480232)
37. Yan, X.D., Pan, L.Y., Yuan, Y., Lang, J.H., and Mao, N. (2007). Identification of platinum-resistance associated proteins through proteomic analysis of human ovarian cancer cells and their platinum-resistant sublines. J Proteome Res 6, 772-780. (Pubitemid 46340180)
38. Yeatman, T.J., Updyke, T.V., Kaetzel, M.A., Dedman, J.R., and Nicolson, G.L. (1993). Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis 11, 37-44. (Pubitemid 23045688)
39. Yoon, Y.M., Baek, K.H., Jeong, S.J., Shin, H.J., Ha, G.H., Jeon, A.H., et al. (2004). WD repeat-containing mitotic checkpoint proteins act as transcriptional repressors during interphase. FEBS Lett 575, 23-29.
40. Zarghami, N., Katsaros, D., Yu, H., and Diamandis, E.P. (1995). Prognostic value of creatine kinase BB isoenzyme in epithelial ovarian carcinoma. Can J Oncol 5, 401-407.